BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17904380)

  • 21. Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells.
    Chung H; Seo S; Moon M; Park S
    J Endocrinol; 2008 Sep; 198(3):511-21. PubMed ID: 18541646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of activation of the 5-HT1A receptor and adenylate cyclase in the antidepressant-like effect of YL-0919, a dual 5-HT1A agonist and selective serotonin reuptake inhibitor.
    Qin JJ; Chen HX; Zhao N; Yuan L; Zhang YZ; Yang RF; Zhang LM; Li YF
    Neurosci Lett; 2014 Oct; 582():104-8. PubMed ID: 25220701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons.
    Decker H; Lo KY; Unger SM; Ferreira ST; Silverman MA
    J Neurosci; 2010 Jul; 30(27):9166-71. PubMed ID: 20610750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
    Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the Akt/GSK-3β/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity.
    Fang W; Gao G; Zhao H; Xia Y; Guo X; Li N; Li Y; Yang Y; Chen L; Wang Q; Li L
    Brain Res; 2015 Mar; 1602():9-19. PubMed ID: 25150591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation.
    Das S; Wong R; Rajapakse N; Murphy E; Steenbergen C
    Circ Res; 2008 Oct; 103(9):983-91. PubMed ID: 18802025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of adenosine receptor subtypes on release and reuptake of hippocampal serotonin.
    Okada M; Kawata Y; Murakami T; Wada K; Mizuno K; Kondo T; Kaneko S
    Eur J Neurosci; 1999 Jan; 11(1):1-9. PubMed ID: 9987006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insufficient Astrocyte-Derived Brain-Derived Neurotrophic Factor Contributes to Propofol-Induced Neuron Death Through Akt/Glycogen Synthase Kinase 3β/Mitochondrial Fission Pathway.
    Liu Y; Yan Y; Inagaki Y; Logan S; Bosnjak ZJ; Bai X
    Anesth Analg; 2017 Jul; 125(1):241-254. PubMed ID: 28622174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Akt and mTOR mediate programmed necrosis in neurons.
    Liu Q; Qiu J; Liang M; Golinski J; van Leyen K; Jung JE; You Z; Lo EH; Degterev A; Whalen MJ
    Cell Death Dis; 2014 Feb; 5(2):e1084. PubMed ID: 24577082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of selective serotonin reuptake inhibitors via 5-HT1A receptors on L-DOPA-induced rotational behavior in a hemiparkinsonian rat model.
    Inden M; Abe M; Minamino H; Takata K; Yoshimoto K; Tooyama I; Kitamura Y
    J Pharmacol Sci; 2012; 119(1):10-9. PubMed ID: 22510520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncotoxic Properties of Serotonin Transporter Inhibitors and 5-HT
    Walory J; Mielczarek L; Jarończyk M; Koronkiewicz M; Kossakowski J; Bugno R; Bojarski AJ; Chilmonczyk Z
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ras regulates neuronal polarity via the PI3-kinase/Akt/GSK-3beta/CRMP-2 pathway.
    Yoshimura T; Arimura N; Kawano Y; Kawabata S; Wang S; Kaibuchi K
    Biochem Biophys Res Commun; 2006 Feb; 340(1):62-8. PubMed ID: 16343426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
    Zhang J; Huang XY; Ye ML; Luo CX; Wu HY; Hu Y; Zhou QG; Wu DL; Zhu LJ; Zhu DY
    J Neurosci; 2010 Feb; 30(7):2433-41. PubMed ID: 20164327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses.
    Nair VD; Olanow CW
    J Biol Chem; 2008 May; 283(22):15469-78. PubMed ID: 18387957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death.
    Chen G; Bower KA; Ma C; Fang S; Thiele CJ; Luo J
    FASEB J; 2004 Jul; 18(10):1162-4. PubMed ID: 15132987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
    Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADP-stimulated activation of Akt during integrin outside-in signaling promotes platelet spreading by inhibiting glycogen synthase kinase-3β.
    O'Brien KA; Gartner TK; Hay N; Du X
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2232-40. PubMed ID: 22814751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine.
    Li XM; Perry KW; Wong DT
    Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.